Global Liver Disease Diagnostics Market by End-use (Hospital, Laboratories), by Diagnosis Technique (Endoscopy, Imaging, Biopsy, Laboratory Tests) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global liver disease diagnostics market was valued at USD 29.3 Billion in 2019. It is expected to grow at a compound annual rate (CAGR of 6.5%) between 2020 and 2027. The market for liver disease diagnostics is expected to grow due to the rising prevalence of chronic and acute liver diseases. According to the WHO, 841,080 cases of liver cancer were diagnosed worldwide in 2018. An estimated 781 631 people died from liver cancer. Key players are expected to increase the demand for diagnostics for liver diseases. In February 2019, Abbott was awarded a CE Mark for the Determine HBsAg2 test. This is a rapid, sensitive and easy-to-use diagnostic test that detects hepatitis B.
The market for liver disease diagnostics is expected to grow due to increased R&D in accurate diagnostic systems that can be used to diagnose early and improve patient outcomes. F. Hoffmann-La Roche Ltd. received Breakthrough Device Designation in March 2020 for Elecsys GALD score. Roche Diagnostics Liver Indication Program developed Elecsys GALAD Score to improve diagnostic workflows and provide accurate information for clinicians.
Market growth for liver disease diagnostics will be accelerated by the availability of favorable reimbursement policies from Medicare and Medicaid. CodeMap is a major source of reimbursement solutions and Medicare compliance includes piccolo Express liver panel plus, developed by Abbott, with a medicare reimbursement amount of USD 30.89.
The market for diagnostics of liver diseases will be impacted by the development of new methods to diagnose disease. Ortho Clinical Diagnostics developed VITROS ALTV slides, a novel method to measure Alanine Aminotransferase, (ALT), using dry slide technology. This innovative method reduces sample volume, increases sensitivity and improves precision performance.
Diagnosis Technique Insights
In 2019, the imaging segment was dominant in the market, with a 29.4% revenue share. The rising number of key players in this market for liver disease diagnostics and advanced imaging techniques can be attributed to their dominance. To diagnose liver function, laboratory tests can be performed using blood and urine samples. The imaging options include X-rays, ultrasound, magnetic resonance imaging (MRI), scans using Computed Tomography (CT), and other tests. The forecast period will see imaging experience a 6.9% CAGR.
The market leaders in liver disease diagnostics are also supporting non-profit organizations in raising awareness and helping physicians to detect liver diseases. Echosens donated FibroScan in January 2020 to Fatty Liver Foundation (FLF). This FibroScan was designed to assist clinicians in the detection, monitoring and prevention of liver disease.
End-use Insights
In 2019, the hospitals segment accounted for 45.5% of the total revenue. This is because patients depend on hospitals that are well-equipped with diagnostic testing equipment. Hospitals offer optimal care and allow for early diagnosis and treatment, which is a key factor in the growth of the market to diagnose liver diseases. The existing hospitals will be enhanced by the continuous development of healthcare infrastructure.
Over the next few years, the market for liver disease diagnostics is expected to grow at the fastest pace in the laboratories segment. Different institutes and laboratories offer awareness programs for the diagnosis of hepatic organ diseases. In December 2017, Mylan Laboratories and the Institute of Liver and Biliary Sciences teamed up to offer awareness and screening programs. This was done to provide screening and testing services for over 1000 patients in Delhi. It performed tests such as Hepatitis C, Fibroscan and ALT.
Regional Insights
North America was the dominant market, with a 43.1% revenue share in 2019. Europe followed. The market for liver disease diagnostics is expected to grow due to high investments in R&D, and the presence of key players. The market for liver disease diagnostics is expected to grow due to the existence of organizations that offer information to patients about diagnosing diseases. One such organization is GetPalliativeCare.org that provides palliative care information related to diagnostic methods such as endoscopy, CT scan, and biopsy.
The Asia Pacific market for liver disease diagnostics is expected to expand at a substantial rate over the forecast period. The market for liver disease diagnostics is growing in Asia Pacific due to an increasing geriatric population. Regional growth will also be driven by the regulatory approval of advanced technologies that are compatible with imaging systems. In August 2018, LiverMultiScan was approved by the Therapeutic Goods Administration (TGA), to diagnose patients suffering from highly prevalent Australian diseases such as NAFLD or NASH.
Market Share Insights & Key Companies
These key players have implemented multiple strategies to develop innovative technologies that will improve patient care. Boston Scientific Corporation purchased BTG plc in August 2019 to provide better patient care. The market leader in liver disease diagnostics is:
-
Abbott
-
F. Hoffmann-La Roche Ltd.
-
Thermo Fisher Scientific Inc.
-
Randox Laboratories Ltd.
-
Boston Scientific Corporation
-
Laboratory Corporation of America Holdings
-
Fujifilm Corporation
-
Horiba Medical
-
Siemens Healthcare GmbH.
Up Market Research published a new report titled “Liver Disease Diagnostics Market research report which is segmented by End-use (Hospital, Laboratories), by Diagnosis Technique (Endoscopy, Imaging, Biopsy, Laboratory Tests), By Players/Companies Boston Scientific Corporation, F Hoffmann-La Roche Ltd, Abbott, Randox Laboratories Ltd, Siemens Healthcare GmbH, Laboratory Corporation of America Holdings, Fujifilm Corporation, Horiba Medical, Thermo Fisher Scientific Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Liver Disease Diagnostics Market Research Report |
| By End-use | Hospital, Laboratories |
| By Diagnosis Technique | Endoscopy, Imaging, Biopsy, Laboratory Tests |
| By Companies | Boston Scientific Corporation, F Hoffmann-La Roche Ltd, Abbott, Randox Laboratories Ltd, Siemens Healthcare GmbH, Laboratory Corporation of America Holdings, Fujifilm Corporation, Horiba Medical, Thermo Fisher Scientific Inc |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 248 |
| Number of Tables & Figures | 174 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Liver Disease Diagnostics Market Report Segments:
The market is segmented by End-use (Hospital, Laboratories), by Diagnosis Technique (Endoscopy, Imaging, Biopsy, Laboratory Tests).
Liver Disease Diagnostics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Liver Disease Diagnostics Market
Overview of the regional outlook of the Liver Disease Diagnostics Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Liver Disease Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Liver Disease Diagnostics Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Hospital
2. Laboratories
7. By Diagnosis Technique:1. Endoscopy
2. Imaging
3. Biopsy
4. Laboratory Tests
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liver Disease Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Liver Disease Diagnostics Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Liver Disease Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Liver Disease Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Liver Disease Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Liver Disease Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Liver Disease Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Liver Disease Diagnostics Market Size and Y-o-Y Growth
4.5.2 Liver Disease Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Liver Disease Diagnostics Market Analysis and Forecast by End-use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End-use
5.1.2 Basis Point Share (BPS) Analysis by End-use
5.1.3 Absolute $ Opportunity Assessment by End-use
5.2 Liver Disease Diagnostics Market Size Forecast by End-use
5.2.1 Hospital
5.2.2 Laboratories
5.3 Market Attractiveness Analysis by End-use
Chapter 6 Global Liver Disease Diagnostics Market Analysis and Forecast by Diagnosis Technique
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Diagnosis Technique
6.1.2 Basis Point Share (BPS) Analysis by Diagnosis Technique
6.1.3 Absolute $ Opportunity Assessment by Diagnosis Technique
6.2 Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
6.2.1 Endoscopy
6.2.2 Imaging
6.2.3 Biopsy
6.2.4 Laboratory Tests
6.3 Market Attractiveness Analysis by Diagnosis Technique
Chapter 7 Global Liver Disease Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Liver Disease Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Liver Disease Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Liver Disease Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Liver Disease Diagnostics Market Size Forecast by End-use
9.6.1 Hospital
9.6.2 Laboratories
9.7 Basis Point Share (BPS) Analysis by End-use
9.8 Absolute $ Opportunity Assessment by End-use
9.9 Market Attractiveness Analysis by End-use
9.10 North America Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
9.10.1 Endoscopy
9.10.2 Imaging
9.10.3 Biopsy
9.10.4 Laboratory Tests
9.11 Basis Point Share (BPS) Analysis by Diagnosis Technique
9.12 Absolute $ Opportunity Assessment by Diagnosis Technique
9.13 Market Attractiveness Analysis by Diagnosis Technique
Chapter 10 Europe Liver Disease Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Liver Disease Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Liver Disease Diagnostics Market Size Forecast by End-use
10.6.1 Hospital
10.6.2 Laboratories
10.7 Basis Point Share (BPS) Analysis by End-use
10.8 Absolute $ Opportunity Assessment by End-use
10.9 Market Attractiveness Analysis by End-use
10.10 Europe Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
10.10.1 Endoscopy
10.10.2 Imaging
10.10.3 Biopsy
10.10.4 Laboratory Tests
10.11 Basis Point Share (BPS) Analysis by Diagnosis Technique
10.12 Absolute $ Opportunity Assessment by Diagnosis Technique
10.13 Market Attractiveness Analysis by Diagnosis Technique
Chapter 11 Asia Pacific Liver Disease Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Liver Disease Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Liver Disease Diagnostics Market Size Forecast by End-use
11.6.1 Hospital
11.6.2 Laboratories
11.7 Basis Point Share (BPS) Analysis by End-use
11.8 Absolute $ Opportunity Assessment by End-use
11.9 Market Attractiveness Analysis by End-use
11.10 Asia Pacific Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
11.10.1 Endoscopy
11.10.2 Imaging
11.10.3 Biopsy
11.10.4 Laboratory Tests
11.11 Basis Point Share (BPS) Analysis by Diagnosis Technique
11.12 Absolute $ Opportunity Assessment by Diagnosis Technique
11.13 Market Attractiveness Analysis by Diagnosis Technique
Chapter 12 Latin America Liver Disease Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Liver Disease Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Liver Disease Diagnostics Market Size Forecast by End-use
12.6.1 Hospital
12.6.2 Laboratories
12.7 Basis Point Share (BPS) Analysis by End-use
12.8 Absolute $ Opportunity Assessment by End-use
12.9 Market Attractiveness Analysis by End-use
12.10 Latin America Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
12.10.1 Endoscopy
12.10.2 Imaging
12.10.3 Biopsy
12.10.4 Laboratory Tests
12.11 Basis Point Share (BPS) Analysis by Diagnosis Technique
12.12 Absolute $ Opportunity Assessment by Diagnosis Technique
12.13 Market Attractiveness Analysis by Diagnosis Technique
Chapter 13 Middle East & Africa (MEA) Liver Disease Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Liver Disease Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Liver Disease Diagnostics Market Size Forecast by End-use
13.6.1 Hospital
13.6.2 Laboratories
13.7 Basis Point Share (BPS) Analysis by End-use
13.8 Absolute $ Opportunity Assessment by End-use
13.9 Market Attractiveness Analysis by End-use
13.10 Middle East & Africa (MEA) Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
13.10.1 Endoscopy
13.10.2 Imaging
13.10.3 Biopsy
13.10.4 Laboratory Tests
13.11 Basis Point Share (BPS) Analysis by Diagnosis Technique
13.12 Absolute $ Opportunity Assessment by Diagnosis Technique
13.13 Market Attractiveness Analysis by Diagnosis Technique
Chapter 14 Competition Landscape
14.1 Liver Disease Diagnostics Market: Competitive Dashboard
14.2 Global Liver Disease Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific Corporation
14.3.2 F Hoffmann-La Roche Ltd
14.3.3 Abbott
14.3.4 Randox Laboratories Ltd
14.3.5 Siemens Healthcare GmbH
14.3.6 Laboratory Corporation of America Holdings
14.3.7 Fujifilm Corporation
14.3.8 Horiba Medical
14.3.9 Thermo Fisher Scientific Inc
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Liver Disease Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Liver Disease Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Liver Disease Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Liver Disease Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Liver Disease Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Liver Disease Diagnostics Market Size and Y-o-Y Growth
4.5.2 Liver Disease Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Liver Disease Diagnostics Market Analysis and Forecast by End-use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End-use
5.1.2 Basis Point Share (BPS) Analysis by End-use
5.1.3 Absolute $ Opportunity Assessment by End-use
5.2 Liver Disease Diagnostics Market Size Forecast by End-use
5.2.1 Hospital
5.2.2 Laboratories
5.3 Market Attractiveness Analysis by End-use
Chapter 6 Global Liver Disease Diagnostics Market Analysis and Forecast by Diagnosis Technique
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Diagnosis Technique
6.1.2 Basis Point Share (BPS) Analysis by Diagnosis Technique
6.1.3 Absolute $ Opportunity Assessment by Diagnosis Technique
6.2 Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
6.2.1 Endoscopy
6.2.2 Imaging
6.2.3 Biopsy
6.2.4 Laboratory Tests
6.3 Market Attractiveness Analysis by Diagnosis Technique
Chapter 7 Global Liver Disease Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Liver Disease Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Liver Disease Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Liver Disease Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Liver Disease Diagnostics Market Size Forecast by End-use
9.6.1 Hospital
9.6.2 Laboratories
9.7 Basis Point Share (BPS) Analysis by End-use
9.8 Absolute $ Opportunity Assessment by End-use
9.9 Market Attractiveness Analysis by End-use
9.10 North America Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
9.10.1 Endoscopy
9.10.2 Imaging
9.10.3 Biopsy
9.10.4 Laboratory Tests
9.11 Basis Point Share (BPS) Analysis by Diagnosis Technique
9.12 Absolute $ Opportunity Assessment by Diagnosis Technique
9.13 Market Attractiveness Analysis by Diagnosis Technique
Chapter 10 Europe Liver Disease Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Liver Disease Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Liver Disease Diagnostics Market Size Forecast by End-use
10.6.1 Hospital
10.6.2 Laboratories
10.7 Basis Point Share (BPS) Analysis by End-use
10.8 Absolute $ Opportunity Assessment by End-use
10.9 Market Attractiveness Analysis by End-use
10.10 Europe Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
10.10.1 Endoscopy
10.10.2 Imaging
10.10.3 Biopsy
10.10.4 Laboratory Tests
10.11 Basis Point Share (BPS) Analysis by Diagnosis Technique
10.12 Absolute $ Opportunity Assessment by Diagnosis Technique
10.13 Market Attractiveness Analysis by Diagnosis Technique
Chapter 11 Asia Pacific Liver Disease Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Liver Disease Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Liver Disease Diagnostics Market Size Forecast by End-use
11.6.1 Hospital
11.6.2 Laboratories
11.7 Basis Point Share (BPS) Analysis by End-use
11.8 Absolute $ Opportunity Assessment by End-use
11.9 Market Attractiveness Analysis by End-use
11.10 Asia Pacific Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
11.10.1 Endoscopy
11.10.2 Imaging
11.10.3 Biopsy
11.10.4 Laboratory Tests
11.11 Basis Point Share (BPS) Analysis by Diagnosis Technique
11.12 Absolute $ Opportunity Assessment by Diagnosis Technique
11.13 Market Attractiveness Analysis by Diagnosis Technique
Chapter 12 Latin America Liver Disease Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Liver Disease Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Liver Disease Diagnostics Market Size Forecast by End-use
12.6.1 Hospital
12.6.2 Laboratories
12.7 Basis Point Share (BPS) Analysis by End-use
12.8 Absolute $ Opportunity Assessment by End-use
12.9 Market Attractiveness Analysis by End-use
12.10 Latin America Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
12.10.1 Endoscopy
12.10.2 Imaging
12.10.3 Biopsy
12.10.4 Laboratory Tests
12.11 Basis Point Share (BPS) Analysis by Diagnosis Technique
12.12 Absolute $ Opportunity Assessment by Diagnosis Technique
12.13 Market Attractiveness Analysis by Diagnosis Technique
Chapter 13 Middle East & Africa (MEA) Liver Disease Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Liver Disease Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Liver Disease Diagnostics Market Size Forecast by End-use
13.6.1 Hospital
13.6.2 Laboratories
13.7 Basis Point Share (BPS) Analysis by End-use
13.8 Absolute $ Opportunity Assessment by End-use
13.9 Market Attractiveness Analysis by End-use
13.10 Middle East & Africa (MEA) Liver Disease Diagnostics Market Size Forecast by Diagnosis Technique
13.10.1 Endoscopy
13.10.2 Imaging
13.10.3 Biopsy
13.10.4 Laboratory Tests
13.11 Basis Point Share (BPS) Analysis by Diagnosis Technique
13.12 Absolute $ Opportunity Assessment by Diagnosis Technique
13.13 Market Attractiveness Analysis by Diagnosis Technique
Chapter 14 Competition Landscape
14.1 Liver Disease Diagnostics Market: Competitive Dashboard
14.2 Global Liver Disease Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific Corporation
14.3.2 F Hoffmann-La Roche Ltd
14.3.3 Abbott
14.3.4 Randox Laboratories Ltd
14.3.5 Siemens Healthcare GmbH
14.3.6 Laboratory Corporation of America Holdings
14.3.7 Fujifilm Corporation
14.3.8 Horiba Medical
14.3.9 Thermo Fisher Scientific Inc
Segments Covered in the Report
The global Liver Disease Diagnostics market has been segmented based on
By End-use
The global Liver Disease Diagnostics market has been segmented based on
By End-use
- Hospital
- Laboratories
- Endoscopy
- Imaging
- Biopsy
- Laboratory Tests
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Boston Scientific Corporation
- F Hoffmann-La Roche Ltd
- Abbott
- Randox Laboratories Ltd
- Siemens Healthcare GmbH
- Laboratory Corporation of America Holdings
- Fujifilm Corporation
- Horiba Medical
- Thermo Fisher Scientific Inc
Our Clients
Related Reports
Some other reports from this category!
